Factors Associated With Functional Decline in Hand and Hip/Knee Osteoarthritis After One Year: Data From a Population-Based Study

Arthritis Care Res (Hoboken). 2021 Sep;73(9):1343-1353. doi: 10.1002/acr.24404. Epub 2021 Jul 27.

Abstract

Objective: To investigate factors that together with hand or hip/knee osteoarthritis (OA) could contribute to functional decline over a year's time in elderly individuals.

Methods: The data of 1,886 individuals between ages 65 and 85 years in a prospective, observational population-based study with 12-18 months of follow-up in the context of the European Project on Osteoarthritis were analyzed. The outcome measures were self-reported hand and hip/knee functional decline, evaluated using a minimum clinically important difference of 4 on the Australian/Canadian Hand OA Index and of 2 on the Western Ontario and McMaster Universities Osteoarthritis Index hip/knee physical function subscales, both normalized to 0-100. Using regression models adjusted for sex, age, country, and education level, the baseline factors considered were clinical hand or hip/knee OA, pain, analgesic/antiinflammatory medications, comorbidities, social isolation, income, walking time, grip strength, physical activity time, and medical/social care.

Results: After a year, 453 participants were identified as having worse hand functionality and 1,389 as not worse. Hand OA, anxiety, walking time, and grip strength were risk factors for hand functional decline; pain was a confounder of the effect of hand OA. Analgesic/antiinflammatory medications mediated the combined effect of hip/knee OA plus pain on functional decline in the 554 individuals classified as having worse hip/knee functionality and the 1,291 persons who were not worse. Peripheral artery disease, obesity, and cognitive impairment were other baseline risk factors.

Conclusion: Study findings showed that together with emotional status and chronic physical and cognitive conditions, OA affects hand and hip/knee functional decline.

Publication types

  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antirheumatic Agents / therapeutic use
  • Cognition
  • Comorbidity
  • Disability Evaluation
  • Disease Progression
  • Emotions
  • Europe / epidemiology
  • Female
  • Functional Status
  • Hand Joints / drug effects
  • Hand Joints / physiopathology*
  • Hip Joint / drug effects
  • Hip Joint / physiopathology*
  • Humans
  • Knee Joint / drug effects
  • Knee Joint / physiopathology*
  • Longitudinal Studies
  • Male
  • Mental Health
  • Minimal Clinically Important Difference
  • Osteoarthritis, Hip / diagnosis
  • Osteoarthritis, Hip / drug therapy
  • Osteoarthritis, Hip / epidemiology
  • Osteoarthritis, Hip / physiopathology*
  • Osteoarthritis, Knee / diagnosis
  • Osteoarthritis, Knee / drug therapy
  • Osteoarthritis, Knee / epidemiology
  • Osteoarthritis, Knee / physiopathology*
  • Patient Reported Outcome Measures
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Antirheumatic Agents